CUE (STOCKS)
Cue Biopharma, Inc.
$0.389900
-0.112000 (-22.32%)
Prev close: $0.501900
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Lucinda Warren
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $44.79M
- Employees
- 41
- P/E (TTM)
- -1.51
- P/B (TTM)
- 1.83
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $27.47M |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $54.02M |
| Nonoperating Income/Loss | $450.00K |
| Operating Expenses | $54.02M |
| Depreciation and Amortization | $958.00K |
| Research and Development | $37.74M |
| Other Operating Expenses | $15.32M |
| Operating Income/Loss | -$26.55M |
| Income/Loss From Continuing Operations After Tax | -$26.60M |
| Income/Loss From Continuing Operations Before Tax | $27.47M |
| Income Tax Expense/Benefit | $500.00K |
| Interest And Dividend Income, Operating | -$257.00K |
| Interest Expense, Operating | $100.00K |
| Interest Income/Expense After Provision For Losses | -$357.00K |
| Interest Income/Expense Operating, Net | -$357.00K |
| Net Income/Loss | -$26.60M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$26.60M |
| Net Income/Loss Available To Common Stockholders, Basic | -$26.60M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$0.28 |
| Diluted Earnings Per Share | -$0.28 |
| Basic Average Shares | 94,731,768 |
| Diluted Average Shares | 94,731,768 |
| Assets | $42.21M |
| Current Assets | $36.98M |
| Noncurrent Assets | $5.23M |
| Fixed Assets | $241.00K |
| Other Non-current Assets | $4.99M |
| Liabilities | $15.78M |
| Current Liabilities | $13.49M |
| Accounts Payable | $3.95M |
| Other Current Liabilities | $9.55M |
| Noncurrent Liabilities | $2.29M |
| Equity | $26.43M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $26.43M |
| Liabilities And Equity | $42.21M |
| Net Cash Flow From Operating Activities | -$21.69M |
| Net Cash Flow From Operating Activities, Continuing | -$21.69M |
| Net Cash Flow From Investing Activities | $75.00K |
| Net Cash Flow From Investing Activities, Continuing | $75.00K |
| Net Cash Flow From Financing Activities | $26.29M |
| Net Cash Flow From Financing Activities, Continuing | $26.29M |
| Net Cash Flow | $4.68M |
| Net Cash Flow, Continuing | $4.68M |
| Comprehensive Income/Loss | -$26.60M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$26.60M |
| Other Comprehensive Income/Loss | $0.00 |